Below are MBC trials that have been added to BreastCancerTrials.org (BCT) in the last month. These trials can also be found on Metastatic Trial Search (MTS)

ALL MBC

• • Molecular Profiling to Study Treatment Selection for Advanced Breast Cancer 
  • Using Personalized T-Cells Along with Chemotherapy to Treat Metastatic Breast Cancer
  • Keytruda plus Bacterial Therapy for Advanced Breast (and Other) Tumors
  • GEN1029 for Advanced Breast (and Other) Cancer
  • ABBV-155 for Advanced Breast (and Other) Cancers

Hormone Receptor Positive (ER+ and/or PR+)

• • A New Targeted Therapy and Taxol for Advanced Breast Cancer
  • ONC201 for Estrogen Receptor Positive or Triple Negative Metastatic Breast Cancer
  • Tecentriq & Cotellic or Idasanutlin for ER+, HER2- Advanced Breast Cancer

HER2 positive (HER2+)

• • DS-8201a Versus Standard of Care for HER2 Positive Advanced Breast Cancer
  • DS-8201a Plus Immunotherapy for HER2 Positive or HER2 Low Expression Advanced Breast Cancer

Triple Negative

• • A New Targeted Therapy and Taxol for Advanced Breast Cancer
  • ONC201 for Estrogen Receptor Positive or Triple Negative Metastatic Breast Cancer
  • XmAb20717 Immunotherapy for Advanced Triple Negative Breast Cancer

Use Metastatic Trial Search to find all metastatic breast cancer trials that are right for you.

Tags:Her2 PositiveHormone Receptor PositiveTNBC